KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,492,038 | -10.4% | 50,222 | +14.9% | 0.01% | 0.0% |
Q2 2023 | $9,477,646 | +6.1% | 43,706 | -11.1% | 0.01% | 0.0% |
Q1 2023 | $8,933,963 | -2.6% | 49,185 | +4.3% | 0.01% | -16.7% |
Q4 2022 | $9,176,921 | -9.1% | 47,142 | +4.9% | 0.01% | -14.3% |
Q3 2022 | $10,094,465 | +151.3% | 44,944 | +40.4% | 0.01% | +133.3% |
Q2 2022 | $4,016,360 | +5.7% | 32,006 | +4.5% | 0.00% | +50.0% |
Q1 2022 | $3,800,424 | +156.4% | 30,614 | +169.4% | 0.00% | +100.0% |
Q4 2021 | $1,482,000 | +5.6% | 11,363 | -1.0% | 0.00% | 0.0% |
Q3 2021 | $1,404,000 | -2.6% | 11,480 | -9.3% | 0.00% | 0.0% |
Q2 2021 | $1,442,000 | +30.9% | 12,654 | +38.0% | 0.00% | 0.0% |
Q1 2021 | $1,102,000 | +11.7% | 9,169 | -5.6% | 0.00% | 0.0% |
Q4 2020 | $987,000 | +35.4% | 9,712 | +3.0% | 0.00% | 0.0% |
Q3 2020 | $729,000 | -27.2% | 9,431 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,002,000 | +106.2% | 9,431 | +39.7% | 0.00% | 0.0% |
Q1 2020 | $486,000 | – | 6,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |